The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Related Posts
Science Amid Chaos: What Worked During the Pandemic? What Failed?
As the coronavirus spread, researchers worldwide scrambled to find ways to keep people safe. Some efforts were misguided. Others saved…
Nobel Prize in Chemistry Goes to 3 Scientists for Predicting and Creating Proteins
The Nobel, awarded to David Baker of the University of Washington and Demis Hassabis and John M. Jumper of Google…
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a…